Business Description
HCA Healthcare Inc
NAICS : 622110
SIC : 8062
Compare
Compare
Traded in other countries / regions
H1CA34.Brazil2BH.GermanyHCA.Mexico0J1R.UKHCA.USA Description
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | -0.05 | |||||
| Debt-to-Equity | -14.4 | |||||
| Debt-to-EBITDA | 3 | |||||
| Interest Coverage | 5.2 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.71 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.5 | |||||
| 3-Year EBITDA Growth Rate | 17.6 | |||||
| 3-Year EPS without NRI Growth Rate | 23.9 | |||||
| 3-Year FCF Growth Rate | 12.3 | |||||
| 3-Year Book Growth Rate | -5.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 10.85 | |||||
| Future 3-5Y Total Revenue Growth Rate | 4.88 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.38 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 78.75 | |||||
| Days Sales Outstanding | 51.73 | |||||
| Days Payable | 157.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 11.9 | |||||
| 3-Year Average Share Buyback Ratio | 5.8 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.44 | |||||
| Operating Margin % | 15.03 | |||||
| Net Margin % | 9.37 | |||||
| ROE % | Neg. Equity | |||||
| ROA % | 10.92 | |||||
| ROIC % | 17.45 | |||||
| ROC (Joel Greenblatt) % | 34.14 | |||||
| ROCE % | 24.61 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.59 | |||||
| PE Ratio without NRI | 13.26 | |||||
| Shiller PE Ratio | 22.87 | |||||
| Price-to-Owner-Earnings | 15.19 | |||||
| PEG Ratio | 0.84 | |||||
| PS Ratio | 1.28 | |||||
| Price-to-Free-Cash-Flow | 18.46 | |||||
| Price-to-Operating-Cash-Flow | 8.97 | |||||
| EV-to-EBIT | 10.94 | |||||
| EV-to-EBITDA | 8.5 | |||||
| EV-to-Revenue | 1.87 | |||||
| EV-to-FCF | 26.91 | |||||
| Price-to-Projected-FCF | 1.29 | |||||
| Price-to-DCF (Earnings Based) | 0.63 | |||||
| Price-to-DCF (FCF Based) | 0.69 | |||||
| Price-to-Median-PS-Value | 1.42 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.87 | |||||
| Earnings Yield (Greenblatt) % | 9.14 | |||||
| Forward Rate of Return (Yacktman) % | 20.49 |
